A new collaboration with GSK Consumer Healthcare and Johns Hopkins University with corporate leaders in attendance. GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. It researches, manufactures and makes available a broad range of medicines, vaccines and consumer healthcare products. Its Consumer Healthcare business develops and markets consumer-preferred and expert-recommended brands in oral health, pain relief, respiratory, nutrition/gastro-intestinal and skin health. Its vision for the future is to transform the consumer healthcare experience and empower consumer self-care and has sought out JHU as a partner to enable this vision. The company will invest $700,000 this year to seek applications from JHU faculty (including APL)  based on novel science, technologies, materials or processes that will lead to improved consumer health outcomes and that align with GSK’s consumer strategic needs – to improve the quality of human life by enabling people to do more, feel better and live longer. The focus of this funding will be to support pilot projects that provide proof of concept of the feasibility of developing safe and effective non-prescription technologies that address one or more of the areas and topics the company has identified as its priorities. Read more: